After graduating from Johns Hopkins School of Medicine in 1995, Dr. Rochelle Walensky worked in an inner-city hospital in Baltimore. “There were floors of patients with AIDS for whom we could do very little,” said Walensky. “Many of them died.” Highly Active Antiretroviral Therapy (HAART), also known as the triple-drug cocktail, was introduced the next year. Suddenly, AIDS patients were getting better. Fewer were hospitalized. “In my formative training years…
Continue reading “Q&A with Rochelle Walensky Cost-Effective HIV Care”